SHC
Sotera Health Company
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$18.90
−0.68%Year over year
Reported trailing growth
- Revenue
- +8.1%
- EBITDA
- +29.8%
- EBIT
- +40.8%
- EPS
- +578.5%
- Free cash flow
- +1.7%
- Operating cash flow
- +10.6%
Forward estimates
Based on analyst estimates
- Revenue
- +5.4%
- EBITDA
- +42.6%
- EPS
- +79.3%
Three-year CAGR
- Revenue
- +5.1%
- EBITDA
- +4.3%
- EBIT
- +16.5%
- Net income
- +23.2%
- EPS
- +22.5%
- Free cash flow
- +16.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026